Amphastar Pharmaceuticals, Inc. Logo

Amphastar Pharmaceuticals, Inc.

Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.

AMPH | US

Overview

Corporate Details

ISIN(s):
US03209R1032 (+3 more)
LEI:
54930055TH0ZLSAQMJ38
Country:
United States of America
Address:
11570 SIXTH STREET, 91730 RANCHO CUCAMONGA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development, manufacturing, and marketing of complex and technically challenging pharmaceutical products. The company's portfolio primarily consists of generic and proprietary injectable, intranasal, and inhalation drugs. It specializes in complex medications, including biologics, interchangeable biosimilars, and proteins, and also manufactures its own active pharmaceutical ingredients (APIs) such as insulin. Amphastar leverages its state-of-the-art, cGMP-compliant facilities to create innovative drug delivery systems and proprietary technological platforms, targeting difficult-to-produce medications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 00:00
Investor Presentation
Q3 2025 Earnings Presentation
English 3.4 MB
2025-09-03 00:00
Investor Presentation
Wells Fargo Healthcare Presentation
English 3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Amphastar Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.